Are expensive drugs worth it? Rolling out new medicines may be too costly to other patients' health
Are expensive drugs worth it? Rolling out new medicines may be too costly to other patients' health
Cikk tartalma röviden
A new analysis reveals that while new medicines can benefit millions of patients, public spending on them in England over two decades has led to significant trade-offs, suggesting that funds might be better allocated to other health services. The study indicates that the NHS's spending on new drugs has resulted in a net loss of about 1.25 million healthy life years, as funds diverted to new medicines could have supported more health services. Researchers advocate for a more holistic view of drug cost-effectiveness and transparency regarding the consequences of prioritizing new drugs.
AI Médiaelemzés
A Mediaverzum mesterséges intelligencia motorjának automatikus kiértékelése
Hangulat/Élmény
mood-caution
Részrehajlás/Elfogultság
Nem meghatározható
Nyelvi nehézség
Átlagos / Normál
Személyek
Kifejezések Érzelmi Töltete
Pozitív kontextus
benefits, value-for-money
Negatív kontextus
significant trade-offs, net loss, sacrificed QALYs
Központi kifejezések
public spending, health services, new drugs